MedTrace Logo

National, Multi-center, Prospective, and Retrospective Cohort Study.

NCT04520204 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 10000

Last updated 2022-08-03

No results posted yet for this study

Summary

National, multi-center, observational, prospective, and retrospective cohort study. The study does not provide for intervention in routine clinical practice.

Key goals:

• Obtaining real-world evidence on the diagnosis and treatment of AIM in Russian hospitals, including both long- and short-term findings and outcomes (i.e. during hospitalization,

and 6-12 months after the diagnosis establishment).

* Evaluation of the applied approaches to the management of AIM patients for compliance with the clinical recommendations across various hospitals, with a breakdown by equipment status;
* Assessment of patients' treatment adherence after 6 and 12 months.

The expected project duration is 3 years. The study subjects will be recruited during the first 24 months unless the investigators decide to terminate or extend the study period. The period of observation for each patient is 6 to 12 months. The project involves retrospective and prospective collection of information from medical records. All patient data shall be recorded by the Investigator into an approved electronic case report form (eCRF).

Recruitment period: 2020-2022. Expected number of subjects: 10,000.

Conditions

  • Acute Myocardial Infarction

Sponsors & Collaborators

  • Healthy Future

    lead OTHER

Principal Investigators

  • Pevzner · Myasnikov Institute of Clinical Cardiology

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-10-01
Primary Completion
2022-12-31
Completion
2024-12-31

Countries

  • Russia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04520204 on ClinicalTrials.gov